The IL-33/ST2 pathway: therapeutic target and novel biomarker (original) (raw)

• Sims, J. E. IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol. 14, 117–122 (2002).
  Article CAS PubMed Google Scholar
• Tominaga, S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 258, 301–304 (1989).
  Article CAS PubMed Google Scholar
• Trajkovic, V., Sweet, M. J. & Xu, D. T1/ST2 — an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 15, 87–95 (2004).
  Article CAS PubMed Google Scholar
• Meisel, C. et al. Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J. Immunol. 166, 3143–3150 (2001).
  Article CAS PubMed Google Scholar
• Oshikawa, K. et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Resp. Crit. Care Med. 164, 277–281 (2001).
  Article CAS PubMed Google Scholar
• Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B. & Liew, F. Y. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J. Immunol. 173, 145–150 (2004).
  Article CAS PubMed Google Scholar
• Kuroiwa, K., Arai, T., Okazaki, H., Minota, S. & Tominaga, S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 284, 1104–1108 (2001).
  Article CAS PubMed Google Scholar
• Brunner, M. et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med. 30, 1468–1473 (2004).
  Article PubMed Google Scholar
• Barksby, H. E., Lea, S. R., Preshaw, P. M. & Taylor, J. J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149, 217–225 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479–490 (2005). This study identifies IL-33 as the functional ligand of ST2L, documenting the production of Th2-related cytokines both in vitro and in vivo.
  Article CAS PubMed Google Scholar
• Dinarello, C. A. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 23, 461–462 (2005).
  Article CAS PubMed Google Scholar
• Sanada, S. et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 117, 1538–1549 (2007). This was the first study to suggest that IL-33 might act as a fibroblast–cardiomyocyte signalling system. IL-33 was found to be upregulated in fibroblasts when they were subjected to biomechanical strain and to modulate cardiomyocyte NF-κB levels, resulting in resistance to the effects of cardiac pressure overload injury in the in vivo model.
  Article CAS PubMed PubMed Central Google Scholar
• Miller, A. M. et al. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205, 339–346 (2008). This study documents the anti-atherosclerotic effect of exogenous IL-33 administration in the ApoE -null mouse, a model of accelerated atherogenesis. This effect is suggested to be mediated through a shift from a Th1 to a Th2 immune response.
  Article CAS PubMed PubMed Central Google Scholar
• Januzzi, J. L. Jr et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J. Am. Coll. Cardiol. 50, 607–613 (2007). This study builds upon previous data regarding sST2 as a cardiac biomarker, suggesting that serum levels of sST2 might be sensitive enough to distinguish between cardiovascular and non-cardiovascular causes of shortness of breath in patients presenting to the emergency ward.
  Article CAS PubMed Google Scholar
• Xu, Y. et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408, 111–115 (2000).
  Article CAS PubMed Google Scholar
• Michelsen, K. S., Doherty, T. M., Shah, P. K. & Arditi, M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173, 5901–5907 (2004).
  Article CAS PubMed Google Scholar
• Abreu, M. T. & Arditi, M. Innate immunity and toll-like receptors: clinical implications of basic science research. J. Pediatr. 144, 421–429 (2004).
  Article CAS PubMed Google Scholar
• O'Neill, L. A. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Rev. Immunol. 7, 353–364 (2007).
  Article CAS Google Scholar
• Werenskiold, A. K., Hoffmann, S. & Klemenz, R. Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol. Cell. Biol. 9, 5207–5214 (1989).
  CAS PubMed PubMed Central Google Scholar
• Klemenz, R., Hoffmann, S. & Werenskiold, A. K. Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc. Natl Acad. Sci. USA 86, 5708–5712 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Werenskiold, A. K. Characterization of a secreted glycoprotein of the immunoglobulin superfamily inducible by mitogen and oncogene. Eur. J. Biochem. 204, 1041–1047 (1992).
  Article CAS PubMed Google Scholar
• Takagi, T. et al. Identification of the product of the murine ST2 gene. Biochim. Biophys. Acta 1178, 194–200 (1993).
  Article CAS PubMed Google Scholar
• Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. & Tominaga, S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318, 83–87 (1993).
  Article CAS PubMed Google Scholar
• Iwahana, H. et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem. 264, 397–406 (1999).
  Article CAS PubMed Google Scholar
• Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P. & Busslinger, M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13, 1176–1188 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Thomassen, E. et al. Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue. Cell Growth Differ. 6, 179–184 (1995).
  CAS PubMed Google Scholar
• Gachter, T., Werenskiold, A. K. & Klemenz, R. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J. Biol. Chem. 271, 124–129 (1996).
  Article CAS PubMed Google Scholar
• Tominaga, S. et al. Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem. Biophys. Res. Commun. 264, 14–18 (1999).
  Article CAS PubMed Google Scholar
• Iwahana, H. et al. Molecular cloning of the chicken ST2 gene and a novel variant form of the ST2 gene product, ST2LV. Biochim. Biophys. Acta 1681, 1–14 (2004).
  Article CAS PubMed Google Scholar
• Lohning, M. et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl Acad. Sci. USA 95, 6930–6935 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Yanagisawa, K. et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J. Biochem. 121, 95–103 (1997).
  Article CAS PubMed Google Scholar
• Xu, D. et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187, 787–794 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Rossler, U. et al. Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1-binding proteins, are differently expressed in vivo. Dev. Biol. 168, 86–97 (1995).
  Article CAS PubMed Google Scholar
• Kumar, S., Tzimas, M. N., Griswold, D. E. & Young, P. R. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 235, 474–478 (1997).
  Article CAS PubMed Google Scholar
• Tago, K. et al. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem. Biophys. Res. Commun. 285, 1377–1383 (2001).
  Article CAS PubMed Google Scholar
• Kumar, S., Minnich, M. D. & Young, P. R. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J. Biol. Chem. 270, 27905–27913 (1995).
  Article CAS PubMed Google Scholar
• Baekkevold, E. S. et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163, 69–79 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl Acad. Sci. USA 104, 282–287 (2007). This study documents the intranuclear properties of IL-33. IL-33 was found to be heterochromatin-associated in human endothelial cells, exerting a repressive effect on DNA transcription. The authors identify a conserved N-terminal motif that is necessary and sufficient for targeting IL-33 to the nucleus.
  Article CAS PubMed Google Scholar
• Sharma, S. et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J. Immunol. 180, 5477–5482 (2008).
  Article CAS PubMed Google Scholar
• Gadina, M. & Jefferies, C. A. IL-33: a sheep in wolf's clothing? Sci. STKE 390, pe31 (2007).
  Google Scholar
• Keller, M., Ruegg, A., Werner, S. & Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818–831 (2008).
  Article CAS PubMed Google Scholar
• Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2, 675–680 (2001).
  Article CAS Google Scholar
• Palmer, G. et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 42, 358–364 (2008).
  Article CAS PubMed Google Scholar
• Chackerian, A. A. et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551–2555 (2007). This study characterizes the IL-33 receptor as ST2L and the IL-1R accessory protein (IL-1RAcP).
  Article CAS PubMed Google Scholar
• Ali, S. et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl Acad. Sci. USA 104, 18660–18665 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Funakoshi-Tago, M. et al. TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell. Signal. 20, 1679–1686 (2008).
  Article CAS PubMed Google Scholar
• Brint, E. K. et al. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction. J. Biol. Chem. 277, 49205–49211 (2002).
  Article CAS PubMed Google Scholar
• Brint, E. K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nature Immunol. 5, 373–379 (2004). This study suggests that ST2L negatively regulates TLR-4 signalling by sequestering the adaptor proteins MAL and MyD88. Furthermore, ST2 -null mice did not develop tolerance to repeated LPS exposure.
  Article CAS Google Scholar
• Kondo, Y. et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20, 791–800 (2008).
  Article CAS PubMed Google Scholar
• Oshikawa, K., Yanagisawa, K., Tominaga, S. & Sugiyama, Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin. Exp. Allergy 32, 1520–1526 (2002).
  Article CAS PubMed Google Scholar
• Hayakawa, H., Hayakawa, M., Kume, A. & Tominaga, S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 282, 26369–26380 (2007). The anti-IL-33 effects of sST2 are clarified in this study. Specifically, sST2 is shown to bind IL-33 and suppress activation of NF-κB, as well as abrogate the expression of Th2-associated cytokines.
  Article CAS PubMed Google Scholar
• Komai-Koma, M. et al. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37, 2779–2786 (2007).
  Article CAS PubMed Google Scholar
• Kropf, P. et al. Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. Eur. J. Immunol. 29, 3621–3628 (1999).
  Article CAS PubMed Google Scholar
• Kopf, M. et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245–248 (1993).
  Article CAS PubMed Google Scholar
• Hoshino, K. et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190, 1541–1548 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E. & McKenzie, A. N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191, 1069–1076 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kropf, P. et al. Identification of two distinct subpopulations of _Leishmania major_-specific T helper 2 cells. Infect. Immun. 70, 5512–5520 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ying, S. et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158, 3539–3544 (1997).
  CAS PubMed Google Scholar
• Hogan, S. P. et al. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161, 1501–1509 (1998).
  CAS PubMed Google Scholar
• Coyle, A. J. et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 190, 895–902 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lambrecht, B. N. et al. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106, 551–559 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Allakhverdi, Z., Smith, D. E., Comeau, M. R. & Delespesse, G. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179, 2051–2054 (2007).
  Article CAS PubMed Google Scholar
• Moulin, D. et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40, 216–225 (2007).
  Article CAS PubMed Google Scholar
• Oshikawa, K. et al. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respir. Med. 95, 532–533 (2001).
  Article CAS PubMed Google Scholar
• Wynn, T. A. Fibrotic disease and the TH1/TH2 paradigm. Nature Rev. Immunol. 4, 583–594 (2004).
  Article CAS Google Scholar
• Tajima, S. et al. ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis. Exp. Lung Res. 33, 81–97 (2007).
  Article CAS PubMed Google Scholar
• Tajima, S., Oshikawa, K., Tominaga, S. & Sugiyama, Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124, 1206–1214 (2003).
  Article CAS PubMed Google Scholar
• Amatucci, A. et al. Recombinant ST2 boosts hepatic Th2 response in vivo. J. Leukoc. Biol. 82, 124–132 (2007).
  Article CAS PubMed Google Scholar
• Sweet, M. J. et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166, 6633–6639 (2001).
  Article CAS PubMed Google Scholar
• Wynn, T. A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524–529 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Miltenburg, A. M., van Laar, J. M., de Kuiper, R., Daha, M. R. & Breedveld, F. C. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand. J. Immunol. 35, 603–610 (1992).
  Article CAS PubMed Google Scholar
• Dolhain, R. J., van der Heiden, A. N., ter Haar, N. T., Breedveld, F. C. & Miltenburg, A. M. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 39, 1961–1969 (1996).
  Article CAS PubMed Google Scholar
• Verri, W. A. Jr et al. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl Acad. Sci. USA 105, 2723–2728 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, A. C., Rashid, R. M. & Elamin, E. M. The “T” in trauma: the helper T-cell response and the role of immunomodulation in trauma and burn patients. J. Trauma 63, 1407–1417 (2007).
  CAS PubMed Google Scholar
• Oshikawa, K., Yanagisawa, K., Tominaga, S. & Sugiyama, Y. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem. Biophys. Res. Commun. 299, 18–24 (2002).
  Article CAS PubMed Google Scholar
• Feterowski, C. et al. Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation. Int. Immunol. 17, 1035–1046 (2005).
  Article CAS PubMed Google Scholar
• Klemenz, R., Hoffmann, S., Jaggi, R. & Werenskiold, A. K. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis. Oncogene 4, 799–803 (1989).
  CAS PubMed Google Scholar
• Rossler, U., Andres, A. C., Reichmann, E., Schmahl, W. & Werenskiold, A. K. T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells. Oncogene 8, 609–617 (1993).
  CAS PubMed Google Scholar
• Oshikawa, K., Yanagisawa, K., Ohno, S., Tominaga, S. & Sugiyama, Y. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 165, 1005–1009 (2002).
  Article PubMed Google Scholar
• Weinberg, E. O. et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106, 2961–2966 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Shimpo, M. et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109, 2186–2190 (2004). This study establishes sST2 as a cardiac biomarker, documenting a correlation between sST2 levels in patients presenting to hospital with myocardial infarction and the chance of death or of developing heart failure.
  Article CAS PubMed Google Scholar
• Daniels, L. B. & Maisel, A. S. Natriuretic peptides. J. Am. Coll. Cardiol. 50, 2357–2368 (2007).
  Article CAS PubMed Google Scholar
• Weinberg, E. O. et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107, 721–726 (2003).
  Article PubMed Google Scholar
• Januzzi, J. L. Jr et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 95, 948–954 (2005).
  Article CAS PubMed Google Scholar
• Sabatine, M. S. et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N. Engl. J. Med. 352, 1179–1189 (2005).
  Article CAS PubMed Google Scholar
• Morrow, D. A. et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102, 2031–2037 (2000).
  Article CAS PubMed Google Scholar
• Antman, E. M. et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284, 835–842 (2000).
  Article CAS PubMed Google Scholar
• Sabatine, M. S. et al. Complementary roles for biomarkers of biomechanical strain, ST2 and NT-proBNP, in patients with ST-elevation myocardial infarction. Circulation 117, 1936–1944 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zethelius, B. et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N. Engl. J. Med. 358, 2107–2116 (2008).
  Article CAS PubMed Google Scholar
• Mallory, G., White, P. & Salcedo-Salgar, J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in seventy-two cases. Am. Heart J. 18, 647–671 (1939).
  Article Google Scholar
• Fishbein, M. C., Maclean, D. & Maroko, P. R. The histopathologic evolution of myocardial infarction. Chest 73, 843–849 (1978).
  Article CAS PubMed Google Scholar
• Frangogiannis, N. G., Smith, C. W. & Entman, M. L. The inflammatory response in myocardial infarction. Cardiovascular Res. 53, 31–47 (2002).
  Article CAS Google Scholar
• Hepper, N. G., Pruitt, R. D., Donald, D. E. & Edwards, J. E. The effect of cortisone on experimentally produced myocardial infarcts. Circulation 11, 742–748 (1955).
  Article CAS PubMed Google Scholar
• Johnson, A. S., Scheinberg, S. R., Gerisch, R. A. & Saltzstein, H. C. Effect of cortisone on the size of experimentally produced myocardial infarcts. Circulation 7, 224–228 (1953).
  Article CAS PubMed Google Scholar
• Libby, P., Maroko, P. R., Bloor, C. M., Sobel, B. E. & Braunwald, E. Reduction of experimental myocardial infarct size by corticosteroid administration. J. Clin. Invest. 52, 599–607 (1973).
  Article CAS PubMed PubMed Central Google Scholar
• Opdyke, D. F., Lambert, A., Stoerk, H. C., Zanetti, M. E. & Kuna, S. Failure to reduce the size of experimentally produced myocardial infarcts by cortisone treatment. Circulation 8, 544–548 (1953).
  Article CAS PubMed Google Scholar
• Roberts, R., DeMello, V. & Sobel, B. E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53, I204–206 (1976).
  Article CAS PubMed Google Scholar
• Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135 (2007).
  Article CAS PubMed Google Scholar
• Yang, Z. et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114, 2056–2064 (2006).
  Article CAS PubMed Google Scholar
• Timmers, L. et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ. Res. 102, 257–264 (2008).
  Article CAS PubMed Google Scholar
• Diez, J., Gonzalez, A., Lopez, B. & Querejeta, R. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nature Clin. Pract. Cadiovasc. Med. 2, 209–216 (2005).
  Article CAS Google Scholar
• McKinsey, T. A. & Olson, E. N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest. 115, 538–546 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Marian, A. J. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 355, 58–60 (2000).
  Article CAS PubMed Google Scholar
• Baudino, T. A., Carver, W., Giles, W. & Borg, T. K. Cardiac fibroblasts: friend or foe? Am. J. Physiol. 291, H1015–1026 (2006).
  CAS Google Scholar
• Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551–571 (1997).
  Article CAS PubMed Google Scholar
• Manabe, I., Shindo, T. & Nagai, R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ. Res. 91, 1103–1113 (2002).
  Article CAS PubMed Google Scholar
• Dzau, V. J. & Re, R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 89, 493–498 (1994).
  Article CAS PubMed Google Scholar
• Klug, D., Robert, V. & Swynghedauw, B. Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation. Am. J. Cardiol. 71, 46A–54A (1993).
  Article CAS PubMed Google Scholar
• Pouleur, H. Role of neurohormones in ventricular adaptation and failure. Am. J. Cardiol. 73, 36C–39C (1994).
  Article CAS PubMed Google Scholar
• Weber, K. T. & Brilla, C. G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin–angiotensin–aldosterone system. Circulation 83, 1849–1865 (1991).
  Article CAS PubMed Google Scholar
• Werenskiold, A. K. et al. Bone matrix deposition of T1, a homologue of interleukin 1 receptors. Cell Growth Differ. 6, 171–177 (1995).
  CAS PubMed Google Scholar
• Robertson, A. K. & Hansson, G. K. T cells in atherogenesis: for better or for worse? Arterioscler. Thromb. Vasc. Biol. 26, 2421–2432 (2006).
  Article CAS PubMed Google Scholar
• Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
  Article CAS PubMed Google Scholar
• Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nature Rev. Immunol. 6, 508–519 (2006).
  Article CAS Google Scholar
• Jonasson, L., Holm, J., Skalli, O., Bondjers, G. & Hansson, G. K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131–138 (1986).
  Article CAS PubMed Google Scholar
• Hansson, G. K., Holm, J. & Jonasson, L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135, 169–175 (1989).
  CAS PubMed PubMed Central Google Scholar
• Stemme, S., Rymo, L. & Hansson, G. K. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65, 654–660 (1991).
  CAS PubMed Google Scholar
• Liuzzo, G. et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101, 2883–2888 (2000).
  Article CAS PubMed Google Scholar
• Roselaar, S. E., Kakkanathu, P. X. & Daugherty, A. Lymphocyte populations in atherosclerotic lesions of apoE −/− and LDL receptor−/− mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16, 1013–1018 (1996).
  Article CAS PubMed Google Scholar
• Zhou, X., Nicoletti, A., Elhage, R. & Hansson, G. K. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102, 2919–2922 (2000).
  Article CAS PubMed Google Scholar
• Reardon, C. A. et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 1011–1016 (2001).
  Article CAS PubMed Google Scholar
• Song, L., Leung, C. & Schindler, C. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108, 251–259 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dansky, H. M., Charlton, S. A., Harper, M. M. & Smith, J. D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl Acad. Sci. USA 94, 4642–4646 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Glass, C. K. & Witztum, J. L. Atherosclerosis. the road ahead. Cell 104, 503–516 (2001).
  Article CAS PubMed Google Scholar
• Palinski, W. et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl Acad. Sci. USA 86, 1372–1376 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. & Witztum, J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915–924 (1989).
  Article CAS PubMed Google Scholar
• Witztum, J. L. The oxidation hypothesis of atherosclerosis. Lancet 344, 793–795 (1994).
  Article CAS PubMed Google Scholar
• Nakajima, T. et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ. Res. 93, 106–113 (2003).
  Article CAS PubMed Google Scholar
• Tupin, E. et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199, 417–422 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X., Robertson, A. K., Rudling, M., Parini, P. & Hansson, G. K. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ. Res. 96, 427–434 (2005).
  Article CAS PubMed Google Scholar
• Frostegard, J. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145, 33–43 (1999).
  Article CAS PubMed Google Scholar
• Uyemura, K. et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97, 2130–2138 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, T. S., Yen, H. C., Pan, C. C. & Chau, L. Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19, 734–742 (1999).
  Article CAS PubMed Google Scholar
• Buono, C. et al. Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23, 454–460 (2003).
  Article CAS PubMed Google Scholar
• Gupta, S. et al. IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752–2761 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Whitman, S. C., Ravisankar, P., Elam, H. & Daugherty, A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E−/− mice. Am. J. Pathol. 157, 1819–1824 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mallat, Z. et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ. Res. 89, E41–E45 (2001).
  CAS PubMed Google Scholar
• Buono, C. et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl Acad. Sci. USA 102, 1596–1601 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mallat, Z. et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104, 1598–1603 (2001).
  Article CAS PubMed Google Scholar
• Huber, S. A., Sakkinen, P., David, C., Newell, M. K. & Tracy, R. P. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103, 2610–2616 (2001).
  Article CAS PubMed Google Scholar
• Binder, C. J. et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114, 427–437 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Davenport, P. & Tipping, P. G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163, 1117–1125 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• King, V. L., Szilvassy, S. J. & Daugherty, A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice. Arterioscler. Thromb. Vasc. Biol. 22, 456–461 (2002).
  Article CAS PubMed Google Scholar
• Shimizu, K., Shichiri, M., Libby, P., Lee, R. T. & Mitchell, R. N. Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas. J. Clin. Invest. 114, 300–308 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Leskinen, M. J., Kovanen, P. T. & Lindstedt, K. A. Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques. Biochem. Pharmacol. 66, 1493–1498 (2003).
  Article CAS PubMed Google Scholar
• Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M. & Maeda, N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl Acad. Sci. USA 89, 4471–4475 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Plump, A. S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992).
  Article CAS PubMed Google Scholar
• Zhang, S. H., Reddick, R. L., Piedrahita, J. A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468–471 (1992).
  Article CAS PubMed Google Scholar
• Bresalier, R. S. et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 352, 1092–1102 (2005).
  Article CAS PubMed Google Scholar
• Kerr, D. J. et al. Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N. Engl. J. Med. 357, 360–369 (2007).
  Article CAS PubMed Google Scholar
• Home, P. D. et al. Rosiglitazone evaluated for cardiovascular outcomes — an interim analysis. N. Engl. J. Med. 357, 28–38 (2007).
  Article CAS PubMed Google Scholar
• Nissen, S. E. & Wolski, K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356, 2457–2471 (2007).
  Article CAS PubMed Google Scholar
• Riad, A. et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 180, 6954–6961 (2008).
  Article CAS PubMed Google Scholar
• Ha, T. et al. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc. Res. 68, 224–234 (2005).
  Article CAS PubMed Google Scholar
• Hua, F. et al. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol. 178, 7317–7324 (2007).
  Article CAS PubMed Google Scholar
• Zhu, X. et al. MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes. Am. J. Physiol. 291, H1900–H1909 (2006).
  CAS Google Scholar
• Boraschi, D. & Tagliabue, A. The interleukin-1 receptor family. Vitam. Horm. 74, 229–254 (2006).
  Article CAS PubMed Google Scholar
• Watters, T. M., Kenny, E. F. & O'Neill, L. A. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 85, 411–419 (2007).
  Article CAS PubMed Google Scholar
• Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
  Article CAS PubMed Google Scholar
• Priestle, J. P., Schar, H. P. & Grutter, M. G. Crystallographic refinement of interleukin 1β at 2.0 Å resolution. Proc. Natl Acad. Sci. USA 86, 9667–9671 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Allan, S. M., Tyrrell, P. J. & Rothwell, N. J. Interleukin-1 and neuronal injury. Nature Rev. Immuno. 5, 629–640 (2005).
  Article CAS Google Scholar
• Nicklin, M. J. et al. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79, 718–725 (2002).
  Article CAS PubMed Google Scholar
• Taylor, S. L., Renshaw, B. R., Garka, K. E., Smith, D. E. & Sims, J. E. Genomic organization of the interleukin-1 locus. Genomics 79, 726–733 (2002).
  Article CAS PubMed Google Scholar
• Dale, M. & Nicklin, M. J. Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 57, 177–179 (1999).
  Article CAS PubMed Google Scholar
• Farrar, J. D., Asnagli, H. & Murphy, K. M. T helper subset development: roles of instruction, selection, and transcription. J. Clin. Invest. 109, 431–435 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Smithgall, M. D. et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 11 June 2008 (doi:10.1093/intimm/dxn060).
  Article CAS PubMed Google Scholar
• Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K. & Kita, H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121, 1484–1490 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Palmer, G. et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 42, 358–364 (2008).
  Article CAS PubMed Google Scholar
• Hill, J. A. & Olson, E. N. Cardiac plasticity. N. Engl. J. Med. 358, 1370–1380 (2008).
  Article CAS PubMed Google Scholar
• Grossman, W., Jones, D. & McLaurin, L. P. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56, 56–64 (1975).
  Article CAS PubMed PubMed Central Google Scholar
• Mann, D. L. & Bristow, M. R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111, 2837–2849 (2005).
  Article PubMed Google Scholar
• Frey, N. & Olson, E. N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65, 45–79 (2003).
  Article CAS PubMed Google Scholar
• Jessup, M. & Brozena, S. Heart failure. N. Engl. J. Med. 348, 2007–2018 (2003).
  Article PubMed Google Scholar